Clinical Trials Logo

Clinical Trial Summary

Hypertension is a leading cause of morbidity and mortality globally. Although multiple drugs are frequently used to treat it, in the South Asian context, evidence is lacking on best drug combinations. This trial aims to compare efficacy of three single-pill combinations of two anti-hypertensive agents on 24-hour ambulatory systolic blood pressure among 1968 individuals with hypertension. The trial is a single-blind randomized controlled trial spread across 15 hospitals in India. Single Pill combinations (SPCs): 1) Amlodipine + Perindopril, 2) Perindopril + Indapamide, 3) Amlodipine + Indapamide


Clinical Trial Description

This is a multi-centre, individual randomized single-blind, parallel group, three-armed superiority trial to compare the efficacy of three different single-pill combinations of antihypertensive therapies (Amlodipine/Perindopril, Perindopril/Indapamide, and Amlodipine/Indapamide)on 24-hour ambulatory BP levels in Indians. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05683301
Study type Interventional
Source Centre for Chronic Disease Control, India
Contact Kavita Singh, PhD
Phone 011-41618456
Email kavita@ccdcindia.org
Status Recruiting
Phase Phase 4
Start date August 30, 2022
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT00573742 - Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients N/A
Recruiting NCT06208072 - The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone. N/A
Not yet recruiting NCT05917275 - Multi-Omics to Predict the Blood Pressure Response to Antihypertensives Phase 4
Recruiting NCT06049862 - The Effectiveness of "MaRiTensi" in Increasing Self-Care and Blood Pressure Control: Randomized Controlled Trial N/A
Completed NCT00819104 - A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components Phase 4
Not yet recruiting NCT06091176 - Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension N/A
Recruiting NCT01742702 - HaemoDYNAMICs in Primary and Secondary Hypertension
Recruiting NCT02817204 - Effect of Aerobic EXercise on MiCroVAscular RarefacTION in Chinese Mild HyperteNsive Patients(EXCAVATION-CHN1) Phase 3
Completed NCT00794885 - China Stroke Primary Prevention Trial Phase 4
Active, not recruiting NCT04381520 - Heat-sensitive Moxibustion Self-administration in Patients in the Community With Primary Hypertension: Protocol for a Multi-center, Pragmatic, Non-randomized Trial N/A
Completed NCT00865501 - Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease Phase 3
Active, not recruiting NCT04788563 - A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community N/A
Completed NCT02184858 - Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension Phase 4
Completed NCT03105687 - Effectiveness of SMS Reminders of Blood Pressure-lowering Drugs Intake N/A
Completed NCT01392534 - Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting N/A
Active, not recruiting NCT03015311 - Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients N/A
Enrolling by invitation NCT03470974 - The Effect of Self-Titration and Predictors for Blood Pressure Control in Patients With Hypertension N/A
Active, not recruiting NCT01844570 - Levamlodipine Maleate or Amlodipine Besylate for Treatment of Hypertension: A Comparative Effectiveness Research N/A
Completed NCT01241487 - A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy Phase 4
Completed NCT00882947 - Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH) Phase 4